February is of course awards season thanks to the Grammys and Oscars, and in keeping with tradition we're emotional to erst again offer our have drive along the "best-of" in various categories among the Diabetes Community of interests.

What's unique about our DiabetesMine D-Oscars is that they not only kudos work ended the past year, but also give a nod to those who are continuously influencing the D-Community in positive ways (plus some not-so-good examples).

Below are our picks for the past class — from early 2017 to the starting time weeks of 2018. Winners get access to our special "practical D-Academy Award" icon created by our gifted illustrator supporter, T1-peep Brad Slaight. Yes, he resembles a intense sea diver, but those are actually Blue Circles for diabetes awareness on his head and hands, People!

And therewith… Envelopes Please…

Most Exciting New Diabetes Med: Fiasp

New Fiasp ultra speedy-acting insulin from Novo Nordisk (also authorized parthian Gloam) brings a new injectable to the D-Community, one that starts operative inside minutes and can even off represent dosed 20 minutes after you've started feeding a meal. Okeh, not everyone who's proven it swears by it, simply atomic number 3 famous Diabetes Pedagog and Author Gary Scheiner says, "annear Sanctified Grail is better than no more Sangraal in the least."

Most Progressive Diabetes Policy: FDA's Pre-Certification Pilot Program

Notably, the federal agency has been putting some truly innovative policies into place — from a energy for more generics and biosimiliar medications, to speed up regulatory reviews along drugs and devices, and now also how it oversees software and mobile apps. This past year, the FDA declared a Pre-Certification for Software program Pilot Program that would judge and dub sure as shooting companies arsenic "trustworthy," to leave their products the necessary regulatory nod without the usual prolonged regulative review period. The Diabetes Community was quite visibly a part of this, with visible-source data group Tidepool and others existence named to be part of the pilot for pre-cert process and informing the FDA's work.

Best New D-Tech: Abbott FreeStyle Libre

The new Abbott Libre Loud Glucose Monitoring scheme is a unfrosted achiever. After organism for sale outside the USA for years, this first-of-its-kind product was authorised here in the States in September, marking the FDA's first allowance of a free burning glucose monitoring device that does not any calibration — i.e. patients are not asked to take fingerstick tests to accuracy-check the gimmick. While the first generation product may not provide straight information streaming or alarms care traditional CGMs, the Libre is a whole new animal that brings more options for the D-Community. And it's getting a lot of positive traction among new users in America!

Well-nig Amazing Acquisition: mySugr (by Roche Diabetes Maintenance)

Wow, the less Vienna-based party that makes the MySugr diabetes app got snapped up by Pharma giant Roche  last summer for a sale price equally such atomic number 3 $100 million (!) Huge congrats to founders Wiener Westermann, Fredrik Debong and team! We're big fans of this app and data-sharing platform and its fun twist on "taming the diabetes monster" (lil' monster icon), and we hear that Eastern Samoa of the modern #ATTD18 conference, Roche is in real time referring to MySugr as its "side to patients." We look forward to seeing what Roche force out coif with this persuasive new face.

Champion Comeback from the Threshold: It's a Tie!

Who ready-made the biggest surprise retort this past year? Weeellll, it's a tie betwixt inhaled insulin developer MannKind Corp and t:slim pump maker Tandem Diabetes . Both were equally expected to fail. In fact, each week, IT seems someone is 100% certain the writing on the wall is saying one of these companies will not survive. Yet despite the uncertainty, both remain alive and moving forward.

Tandem Diabetes continues selling devices, building next-gen tech, conducting clinical trials, and expanding to the external market piece hiring more people.

Share on Pinterest

Lag, MannKind's Afrezza remains addressable and they keep hiring new leadership and gross revenue reps too as conducting clinical trials to improve market the product and even move beyond diabetes. Sure, the future is uncharted… simply anyone who claims the end is about, is either lying or believes in their own crystal orb too much.

Share on Pinterest

Charles Herbert Best #WeAreNotWaiting Protagonism Upset: JDRF's Open Protocols Initiatory

Better advanced than never. The big T1D non-profit org launched an initiative that many in the homemade, open-source universe have been clamoring to see for years — an embrace of #WeAreNotWaiting in which JDRF encourages the D-device industry to move toward openness, rather than proprietary products (especially aimed at closed loop technology). Recently at #ATTD18, Roche in public committed to this Open Protocols Enterprisingness, which is good news even though they no longer sell insulin pumps in the U.S. It's as wel great to get it on this runs in parallel with different efforts such as Dexcom's launch of its OpenAPI and collaborative development platform in recent months.

Boldest Doctor Vocalization: Beyond Type 1

With their dynamic graphics and partnerships with apparently everyone in the Dr., and the celebrity clout they bestow to the table, this California non-profit has already made large waves in our D-Community since appearing on the scene just a few age past. BT1 has initiated multiple protagonism campaigns to help individuals and raise awareness — from aiding a little male child in deman of an insulin pump to educating pediatricians around the country on the risks of DKA. We're peculiarly affected with how they jumped in to delivery the online community TuDiabetes, afterward the unexpected folding of the Diabetes Custody Foundation last year.

The Snazzy Dresser (with Diabetes) Award: Type 1 Vesture

For many World Health Organization habiliment diabetes gear, finding fashionable clothing that works can be rather a challenge, from workout gear to wedding ceremony dresses that need special pockets. One of the microscopic D-businesses addressing this issue that got a lot of push during the hold out year was Type 1 Clothing, a emotional UK-based outfit created by fellow T1 PWD Natalie Balmain (aka @msbalmain). They offer a unharmed selection of hip T-shirts and snazzy ladies wear, designed specifically with the diabetes community in mind. See this coverage at Healthline proper to find out many about this particular stylish D-Oscar Winner!

C. H. Best Exoteric Display of Diabetes (PDOD): British Prime Minister Theresa English hawthorn

The prime minister of the Britain, who was diagnosed with T1D A an grownup in 2012, snags the award here, non only for becoming such a prominent face of success with diabetes, only also for so openly talking well-nig and display turned her diabetes and gear, the Abbott FreeStyle Libre sensing element along her arm. At one point last year, she even had a contemptible blood bread and joked about the confect she ate to encouragement her BG at the clock time.

An mention in this class goes to the Apple Watch commercial in September with a mention of diabetes and Continuous Glucose Monitoring (CGM) tech from Dexcom. Nice!

Biggest Oculus-Rolling wave D-Moments: The EXEC

On the rif side of the last category comes those who publicly dissed this disease. Sure, it was an eye-rolling moment when Jimmy Kimmel made a gaff about diabetes last Fall. But the bigger, more impactful flub came at the government level, with the misinformed way the Caucasoid Sign of the zodiac Administration talked about diabetes during President Donald J. Trump's first year. Initiatory, budget director Mick Mulvaney made misinformed comments about diabetes related to healthcare policy, and and so Trump himself threw shade at Dominant Court Department of Justice Sonia Sotomayor (a longtime T1) for ostensibly non being healthy enough for a seat on the bench collectable to her diabetes. Combined with governmental battles over healthcare and dose pricing policies, it's been a frustrating time for our D-Community thanks to the federal government's "leadership." All of this has illustrated wherefore efforts to raise D-Awareness and Advocacy are more life-and-death than ever, if you ask us.

Best Choreography in D- Community of interests: Disaster Mode Responders

One of the biggest stories from this past twelvemonth was the wave of unaffected disasters hitting parts of the USA and encompassing areas. But it was person-enriching to see the D-Community's response to those catastrophes. From the common level to the bigger diabetes non-earnings orgs to the corporate/diligence face, people responded with generous help efforts. We feel that "Serving Hand Accolade" awards should go to all those WHO did what they could in these tough times. Thank you!!

Top-quality Grassroots Diabetes Advocacy: #insulin4all

Yep, it's a hashtag for the win. The #insulin4all initiative, launched by UK-based T1international in 2014 and evolving into a sweeping grassroots social media movement in new days, has acknowledged more in the D-Community a voice many another tactile property they harbor't had with other D-orgs or campaigns.

And in recent months, they've stepped up their efforts to advocate for more affordable and accessible insulin — particularly here in the USA. Known wins include a premiere-of-its-kind law in Nevada aimed at insulin pricing transparence then an in-person insulin-pricing protest at Lilly Diabetes HQ in September, also American Samoa a line of litigation and state legislative actions aimed at insulin pricing transparency. This advocacy actually regard and supplements broader efforts already in situ to fishing gear the insulin affordability crisis — even if the proclaimed #insulin4all advocates sometimes take issue with the strength or merits of opposite efforts.

The Memorable D-Medicine Oscar(s)

Hunky-dory, ii D-Community members caught our ear and earned this sweet award for the past season:

Rocking chair D-Dad Bart Millard: He's a singer-songster in Christian contemporary rock band MercyMe, WHO wrote the song Even If that centers on his teenage boy Surface-to-air missile, diagnosed at age 2. In a testimony-live performance TV, Bart talks some how at its base, this call is about enduring life's challenges — whether it's life with diabetes or some other chronic train, or troubled afterward a family member's death, operating theater those just having a "bad twenty-four hour period." It hits the warmheartedness, particularly at the 3-minute mark of the video, where Bart says he knows that "Sam is expiration to change the human race American Samoa a diabetic."

Canadian hip-hop Singer Chedda Cheese: This rapper who's real name is Shea Rodger is a 20-something from Calgary diagnosed with T1D at Christmas 2016. A year later atomic number 2 wrote a song about it, Diabetes At Christmastide. It's a shorter line at just over 90 seconds, and in media coverage we learn that Shea's brother is also a T1D, diagnosed a few years agone. Shea free this birdcall in late 2017 to arouse cognisance, and honestly, it isn't bad. Plus you just have to appreciate the stage name of "Chedda Cheese"!

Unsurpassed Bearing Role in D-Management: Your Smartphone

And so much in diabetes care comes down to data — from glucose numbers to carb counts and insulin dosing mathematics. And of course, a key tool in all of that is smartphones. You hind end go undecomposable by just using a phone calculator to calculate diabetes info, or use unrivalled of hundreds of mobile apps to view glucose readings or CGM graphs, and eve key in exercise and sleep information. Not everyone has a smartphone, to live sure. But a absolute majority do and this past year has pushed smartphone use in diabetes management to an incomparable in flood.

Mention: A shout-out in the "Best Supportive Role" always has to attend the Fatherly and Supporting Spouses and Partners everywhere. Yes, those of us with someone special in our life know very well that we wouldn't be able to rigging diabetes the way we do without them.

The Angry Oscar: Insulin Pricing Players

We wish this weren't still an publication — and that the same ones who earned this negative D-Oscars recognition live year had changed enough to trip the list. But lamentably, insulin pricing is still in crisis mode. Big Insulin manufacturers are withal unsatisfactory on this advanced. Drugstore Benefit Managers (PBMs) and Insurers are still a part of the problem. In that location is lots of protagonism happening on this front, and some big lawsuits have been filed in the past year or so. Nevertheless the outrage continues. Grrrr.

The Grumbly Award: Medtronic Diabetes

For all the praise and chatter about the Minimed 670G (aka the Hybrid Closed-loop system), MedT dropped the ball on launching this as it had promised and customers expected — with delays in getting the device itself to delays in CGM sensors and related supplies (in part due to hurricane-related manufacturing hiccups in Puerto Rico). But even now, as the troupe proclaims all issues are resolved, people in the D-Residential district uphold sharing how their orders are being delayed, shipments and packages are being mishandled, and customer service corpse a challenge.

(Un)Honorable Acknowledgment: The Terra firma Diabetes Affiliation for its outdated, wrong policy preventing photos at its 2017 yearbook Scientific Sessions meeting. That pic ban became a media story in itself and many a in the DOC and beyond griped about it (including us at the 'Mine), pushing the diabetes org to say it would re-evaluate its insurance for the future.

Lifetime Achievements in D-Protagonism: St. David Mendosa and Keith Campbell

Our D-Community lost leash unthinkable PWDs during the past year, who deserve recognition for the touch on they've made on so many a.

David Mendosa: Reasoned by many to be the "father of the Diabetes Online Community," David began his journey with T2D in 1994 and began writing roughly it online shortly thereafter — when the Cyberspace was motionless in its infancy. He connected many D-peeps over the geezerhood and was a true journalist, let alone an influential D-counsel WHO helped shape conversations about diabetes and tech. We wrote a protection near David following his death in May 2017.

Keith Joseph Campbell: Living with T1D for 68 years, Keith has left-hand a bequest in large part through his work in helping to make over the American Connexion of Diabetes Educators (AADE) four decades agone and in shaping diabetes breeding over the past decades. This is the fib on Keith that we wrote several years ago, and ran again after his exceedingly in November 2017.

Judy Steve Reich: We also real recently straying diabetes advocate and old T1 Judy Reich in Las Vegas, World Health Organization passed away early in February 2018. She was a bright spot and inspirational soul, and we wrote a tribute to her here. She will certainly be missed!

These D-peeps remain in our hearts and their legacies live on in our D-Community.

Overall Better in Diabetes: People

Severely, YOU are the winner here. (Whoa, are there that many D-Oscars available…?)

We believe that all people with diabetes and those in our D-Community of interests — from those who live with T1 or T2 to parents and caregivers, and the medical professionals and others focusing on research or intersection development — deserve recognition here for all they DO. So many POVs exist and flatbottomed when we discord, it's then important to realise and respect those viewpoints and the people tooshie them. Here's to you!!

CONGRATS to all the WINNERS!

If you're curious, be sure to check out our past Diabetes Oscar Winners for 2016 and 2017, and those from 2015 and 2014, excessively.

What do you think, D-Friends?